Association of direct-to-consumer genome-wide disease risk estimates and self-reported disease

Genetic Epidemiology

Volumn 36, Issue 1, 2012, Pages 66-70

  Bloss, Cinnamon S ^a   Topol, Eric J ^a,b,c   Schork, Nicholas J ^a,b  

^a SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SCRIPPS CLINIC   (United States)

Author keywords

Clinical validity; Consumer genomics; Direct to consumer; Genetic risk estimates; Genetic testing

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC RISK; GRAVES DISEASE; HEART INFARCTION; HUMAN; HUMAN GENOME; LUPUS VULGARIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROSTATE CANCER; RESTLESS LEGS SYNDROME; RISK ASSESSMENT;

ALZHEIMER DISEASE; CONSUMER PARTICIPATION; DIABETES MELLITUS, TYPE 2; GENETIC TESTING; GENOME, HUMAN; GRAVES DISEASE; HUMANS; PEDIGREE; RESTLESS LEGS SYNDROME; RISK ASSESSMENT; SELF REPORT;

EID: 84859107502     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20664     Document Type: Article

References (10)

1. Bloss CS, Ornowski L, Silver E, Cargill M, Vanier V, Schork NJ, Topol EJ. 2010. Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genet Med 12:556-566.
2. Bloss CS, Schork NJ, Topol EJ. 2011. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 364:524-534.
3. Hunter DJ, Khoury MJ, Drazen JM. 2008. Letting the genome out of the bottle-will we get our wish? N Engl J Med 358:105-107.
4. Kutz GD. 2010. Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. http://www.gao.gov/new.items/ d10847t.pdf. Date accessed: 07/05/2011.
5. Navigenics. http://www.navigenics.com/. Date accessed: 7/1/2011.
6. Navigenics. 2010. The science behind the Navigenics service. http://www.navigenics.com/static/pdf/Navigenics-TheScience.pdf. Date accessed: 07/05/2011.
7. Ng PC, Murray SS, Levy S, Venter JC. 2009. An agenda for personalized medicine. Nature 461:724-726.
8. Pepe MS. 2003. The Statistical Evaluation of Medical Tests for Classification and Prediction. New York: Oxford University Press, Inc.
9. Ritchie MD, Denny JC, Crawford DC, Ramirez AH, Weiner JB, Pulley JM, Basford MA, Brown-Gentry K, Balser JR, Masys DR, Haines JL, Roden DM. 2010. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 86:560-572.
10. Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ. 2010. Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health 31:69-87.